# VPRIV
> **BLA022575** · Biologics License Application · Sponsor: SHIRE HUMAN GENETIC · Approved 2010-02-26
## Drug
- **FDA Application Number:** BLA022575
- **Application type:** Biologics License Application
- **Brand name:** VPRIV
- **Generic name:** VELAGLUCERASE ALFA
- **Active ingredients:** VELAGLUCERASE ALFA
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** SHIRE HUMAN GENETIC
- **Manufacturer:** Takeda Pharmaceuticals America, Inc.
- **First approval:** 2010-02-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022575)
---
*AI Analytics · CC0 1.0*